Intellectual Property India Publishes Patent Application for 'Lentiviral Particles Displaying Fusion Molecules And Uses Thereof' Filed by Umoja Biopharma, Inc.

MUMBAI, India, June 27 -- Intellectual Property India has published a patent application (202517053790 A) filed by Umoja Biopharma, Inc., Seattle, on June 3, for 'lentiviral particles displaying fusion molecules and uses thereof.'

Inventor(s) include Nicolai, Christopher; Tang, Weiliang; Ryu, Byoung; Larson, Ryan; Qin, Jim; Leung, Wai-Hang; Park, Lisa, Yun; and Mittelsteadt, Kristen.

The application for the patent was published on June 27, under issue no. 26/2025.

According to the abstract released by the Intellectual Property India: "Provided herein are particles comprising polynucleotide constructs for generating cells expressing anti-CD19 chimeric antigen receptor, as well as vectors, such as lentiviral vectors, comprising same, cells...